CPT® Code 0478T

Deleted

1. Indications

The procedure of fetal magnetocardiography (FMCG) is indicated for various clinical scenarios during pregnancy. These include:

• Monitoring Fetal Well-Being This procedure is performed to assess the overall health and well-being of the fetus, particularly during the second and third trimesters of pregnancy.
• Evaluation of Fetal Movement FMCG is utilized to monitor fetal movements, which can provide insights into the fetus's condition and activity levels.
• Assessment of Heart Rate The technique is employed to evaluate the fetal heart rate, which is a critical parameter in determining fetal health.
• Detection of Cardiac Arrhythmias FMCG can help identify the presence or absence of cardiac arrhythmias, which may indicate underlying fetal cardiac issues.
• Screening for Congenital Cardiac Disease This procedure is also indicated for the detection of potential congenital cardiac diseases in the fetus, allowing for early intervention if necessary.

2. Procedure

The procedure for fetal magnetocardiography (FMCG) involves several key steps to ensure accurate recording and analysis of the fetal cardiac signals. These steps include:

• Electrode Placement Initially, a pair of electrodes is carefully placed on the maternal abdomen to capture the fetal magnetic signals. A third electrode is positioned on the maternal chest to enhance the quality of the recordings. This strategic placement is crucial for obtaining clear and reliable data from the fetal heart.
• Recording of Fetal Magnetic Cardiac Signals Once the electrodes are in place, the system begins to record the fetal magnetic cardiac signals. This process involves capturing the small magnetic fields generated by the electrical activity of the fetal heart, which are then transmitted through the maternal abdomen.
• Data Separation and Analysis After recording, the collected data is separated into fetal and maternal components. This separation is essential for accurate analysis, as it allows healthcare professionals to focus specifically on the fetal cardiac signals without interference from maternal data.
• Review and Interpretation Following the data analysis, a physician or other qualified healthcare professional reviews the results. This step involves interpreting the recorded signals to assess fetal well-being, identify any potential cardiac arrhythmias, and evaluate for signs of congenital cardiac disease.
• Reporting Finally, a comprehensive report is generated based on the review and interpretation of the data. This report provides critical information regarding the fetal cardiac condition and is essential for guiding further clinical decisions.

3. Post-Procedure

After the completion of the fetal magnetocardiography (FMCG) procedure, the patient may be advised on several post-procedure considerations. Typically, there are no specific restrictions or recovery protocols required following FMCG, as it is a non-invasive procedure. However, healthcare providers may recommend monitoring for any unusual symptoms or changes in fetal movement. The results of the FMCG will be discussed with the patient, and any necessary follow-up actions or additional testing will be determined based on the findings. It is important for patients to maintain regular prenatal care and communicate any concerns to their healthcare provider following the procedure.